Freedman Financial Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-260
Closed -$20K 67
2022
Q1
$20K Buy
260
+120
+86% +$9.51K 0.01% 294
2021
Q4
$12K Hold
140
0.01% 321
2021
Q3
$11K Hold
140
0.01% 338
2021
Q2
$11K Hold
140
0.01% 335
2021
Q1
$11K Hold
140
0.01% 344
2020
Q4
$12K Buy
+140
New +$11.6K 0.01% 333

Other funds holding CL

Freedman Financial Associates's CL Position: Q2 2022 in Review

Freedman Financial Associates sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 260 shares — an estimated $20K sold.

Freedman Financial Associates first reported a position in CL in Q4 2020 and held it in 6 quarters. The position peaked at $20K in Q1 2022. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • Freedman Financial Associates reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
  • Freedman Financial Associates sold 260 Colgate-Palmolive shares in Q2 2022, an estimated $20K.
  • Freedman Financial Associates first reported a position in Colgate-Palmolive in Q4 2020 and held it in 6 quarters.
  • Freedman Financial Associates's Colgate-Palmolive position peaked at $20K in Q1 2022.
  • 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Freedman Financial Associates's 13F filing for Q2 2022.